LYEL · Lyell Immunopharma, Inc.
Market Cap
$356.06M
Shares
24.51M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-14 | 18 | $13.74 | $247 |
| 2026-08-13 | 17 | $14.17 | $241 |
| 2026-08-03 | 8 | $12.94 | $104 |
| 2026-07-28 | 79 | $12.96 | $1,024 |
| 2026-07-27 | 4,656 | $12.63 | $58,805 |
| 2026-07-21 | 19,575 | $12.92 | $252,909 |
| 2026-07-16 | 171 | $14.26 | $2,438 |
| 2026-07-09 | 246 | $15.40 | $3,788 |
| 2026-06-22 | 334 | $12.74 | $4,255 |
| 2026-06-18 | 2,495 | $12.52 | $31,237 |
| 2026-06-15 | 142 | $13.50 | $1,917 |
| 2026-06-04 | 13,798 | $12.57 | $173,441 |
Showing 1–12 of 12 settlements
Key facts
CIK
1806952
CUSIP
55083R203
13F (30d)
90 filings
85 filers
Visit website
Investor relations